New drug may help reduce diabetic vision loss
Pill reduces risk of vision loss caused by diabetic retinopathy by 41 percent, according to data from late-stage trials
The drug, ruboxistaurin, which is expected to be sold under the brand name Arxxant if approved, reduced the risk of moderate vision loss by 41 percent, compared with a placebo, the study’s investigators said at the American Diabetes Association scientific meeting in Washington.
“It’s a completely new approach that can help slow down loss of vision,” Dr. Lloyd Paul Aiello, the study’s lead investigator, said in an interview.
http://www.msnbc.msn.com/id/13276184/
Would you like to comment?
